CME Group Inc. $CME Shares Purchased by Bogart Wealth LLC

Bogart Wealth LLC increased its position in shares of CME Group Inc. (NASDAQ:CME) by 1.8% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 58,669 shares of the financial services provider’s stock after acquiring an additional 1,042 shares during the quarter. CME Group makes up approximately 0.7% of Bogart Wealth LLC’s holdings, making the stock its 27th biggest holding. Bogart Wealth LLC’s holdings in CME Group were worth $16,170,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Heartland Bank & Trust Co purchased a new position in CME Group during the first quarter worth approximately $377,000. Catalyst Capital Advisors LLC raised its stake in CME Group by 256.9% during the first quarter. Catalyst Capital Advisors LLC now owns 3,662 shares of the financial services provider’s stock worth $971,000 after purchasing an additional 2,636 shares during the period. OMNI 360 Wealth Inc. purchased a new position in CME Group during the first quarter worth approximately $367,000. Fulcrum Equity Management purchased a new position in CME Group during the first quarter worth approximately $258,000. Finally, AIA Group Ltd raised its stake in CME Group by 17.8% during the first quarter. AIA Group Ltd now owns 16,645 shares of the financial services provider’s stock worth $4,416,000 after purchasing an additional 2,510 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Activity

In other news, Director William R. Shepard purchased 262 shares of the company’s stock in a transaction that occurred on Thursday, September 25th. The shares were purchased at an average price of $265.19 per share, with a total value of $69,479.78. Following the purchase, the director directly owned 258,459 shares of the company’s stock, valued at approximately $68,540,742.21. This represents a 0.10% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, General Counsel Jonathan L. Marcus sold 392 shares of CME Group stock in a transaction on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total transaction of $102,704.00. Following the sale, the general counsel directly owned 7,851 shares in the company, valued at $2,056,962. This trade represents a 4.76% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 13,043 shares of company stock worth $3,527,956. Corporate insiders own 0.30% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on CME. Raymond James Financial cut their price target on shares of CME Group from $309.00 to $307.00 and set an “outperform” rating on the stock in a research note on Monday, October 13th. UBS Group cut their price target on shares of CME Group from $305.00 to $285.00 and set a “neutral” rating on the stock in a research note on Monday, September 8th. Citigroup raised shares of CME Group from a “neutral” rating to a “buy” rating and increased their price target for the stock from $275.00 to $300.00 in a research note on Thursday, September 25th. Piper Sandler increased their price target on shares of CME Group from $283.00 to $296.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 15th. Finally, Keefe, Bruyette & Woods raised their target price on shares of CME Group from $283.00 to $287.00 and gave the company a “market perform” rating in a research note on Monday, October 13th. Seven analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $283.71.

CME Group Stock Performance

Shares of CME stock opened at $267.93 on Monday. The company’s fifty day simple moving average is $267.30 and its 200-day simple moving average is $271.40. CME Group Inc. has a 52 week low of $213.94 and a 52 week high of $290.79. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The company has a market cap of $96.56 billion, a PE ratio of 25.94, a P/E/G ratio of 6.16 and a beta of 0.41.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, beating analysts’ consensus estimates of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The business had revenue of $1.69 billion for the quarter, compared to the consensus estimate of $1.68 billion. During the same quarter last year, the firm posted $2.56 EPS. The business’s revenue for the quarter was up 10.4% compared to the same quarter last year. As a group, equities research analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were paid a dividend of $1.25 per share. The ex-dividend date of this dividend was Tuesday, September 9th. This represents a $5.00 annualized dividend and a yield of 1.9%. CME Group’s payout ratio is 48.40%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.